Raphael Mechoulam
43Patents
15h-index
70Co-inventors
84Inventor score
Filing activity: Dec 28, 1976 → Mar 12, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5538993A | Certain tetrahydrocannabinol-7-oic acid derivatives | Chemistry; Metallurgy | 74 | Expired |
| US4876276A | (3S-4S)-7-hydroxy-.DELTA..sup.6 -tetrahydrocannabinols | Chemistry; Metallurgy | 53 | Expired |
| US5521215A | NMDA-blocking pharmaceuticals | Chemistry; Metallurgy | 46 | Expired |
| US5618955A | Fatty acid derivatives and pharmaceutical compositions containing same | Chemistry; Metallurgy | 40 | Expired |
| US5434295A | Neuroprotective pharmaceutical compositions of 4-phenylpinene derivatives and certain novel 4-phenylpinene compounds | Chemistry; Metallurgy | 40 | Expired |
| US5338753A | (3R,4R)-.DELTA..sup.6 -tetrahydrocannabinol-7-oic acids useful as antiinflammatory agents and analgesics | Human Necessities | 39 | Expired |
| US5635530A | (3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processors for their preparation and pharmaceutical compositions containing them | Chemistry; Metallurgy | 39 | Expired |
| US4179517A | Novel tetrahydrocannabinol type compounds | Human Necessities | 37 | Expired |
| US6096740A | Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions | Chemistry; Metallurgy | 36 | Expired |
| US5284867A | NMDA-blocking pharmaceutical compositions | Chemistry; Metallurgy | 34 | Expired |
| US5932610A | Tumor necrosis factor .alpha. (TNF-.alpha.) inhibiting pharmaceuticals | Emerging Cross-Sectional Technologies | 32 | Expired |
| US4282248A | Pinene derivatives and pharmaceutical compositions containing the same | Chemistry; Metallurgy | 30 | Expired |
| US6410588B1 | Use of cannabinoids as anti-inflammatory agents | Human Necessities | 21 | Expired |
| US8071641B2 | Treating or preventing diabetes with cannabidiol | Human Necessities | 19 | Active |
| US9447019B2 | Fluorinated CBD compounds, compositions and uses thereof | Chemistry; Metallurgy | 18 | Active |
| US7759526B2 | Pharmaceutical compositions comprising cannabidiol derivatives | Chemistry; Metallurgy | 13 | Active |
| US6864291B1 | Agonists specific for the peripheral cannabinoid receptor | Human Necessities | 13 | Expired |
| US6903137B2 | Agonists specific for the peripheral cannabinoid receptor | Human Necessities | 11 | Expired |
| US9782360B2 | Fluorinated CBD compounds, compositions and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US5605928A | Antiemetic compositions | Human Necessities | 11 | Expired |
| US6331560A | Tumor necrosis factor alpha (TNF-.alpha.) inhibiting pharmaceuticals | Emerging Cross-Sectional Technologies | 9 | Expired |
| US8119697B2 | Anti-nausea and anti-vomiting activity of cannabidiol compounds | Human Necessities | 8 | Active |
| US8497299B2 | Compositions including quinonoid derivatives of cannabinoids for therapeutic use | Chemistry; Metallurgy | 8 | Active |
| US6566543B2 | 2-arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor-&agr; and neuroprotector of brain in closed head injury | Human Necessities | 5 | Expired |
| US6531636B1 | Synthetic endogenous cannabinoids analogues and uses thereof | Chemistry; Metallurgy | 4 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.